Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 3/20 | 0.51 |
| ▸ | POLB | P06746 | 2/20 | 0.51 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.51 |
| ▸ | SRC | P12931 | 1/20 | 0.48 |
| ▸ | NR1H3 | Q13133 | 2/20 | 0.47 |
| ▸ | HTT | P42858 | 1/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | PGR | P06401 | 1/20 | 0.47 |
| ▸ | ATM | Q13315 | 1/20 | 0.45 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.44 |
| ▸ | EGFR | P00533 | 1/20 | 0.44 |
| ▸ | ERBB2 | P04626 | 1/20 | 0.44 |
| ▸ | GPBAR1 | Q8TDU6 | 1/20 | 0.43 |
| ▸ | MAOA | P21397 | 1/20 | 0.43 |
| ▸ | GAA | P10253 | 1/20 | 0.43 |
| ▸ | PLAU | P00749 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14388150 | 0.84 | KMT2A (0.45) | KMT2APOLBKDM4ESRCNR1H3 | |
| SCHEMBL9426030 | 0.81 | HDAC6 (0.37) | KMT2APOLBKDM4ESRCNR1H3 | |
| SCHEMBL12173033 | 0.78 | MEN1 (0.49) | KMT2ANR1H3MEN1PGRNR1H2 | |
| SCHEMBL11674185 | 0.77 | NPSR1 (0.43) | KMT2APOLBHTTMEN1ATM | |
| SCHEMBL529884 | 0.76 | POLB (0.64) | KMT2APOLBKDM4ENR1H3HTT | |
| SCHEMBL28867967 | 0.76 | KMT2A (0.64) | KMT2APOLBKDM4ENR1H3HTT | |
| SCHEMBL9001638 | 0.75 | POLB (0.75) | KMT2APOLBKDM4ENR1H3HTT | |
| SCHEMBL493114 | 0.75 | KMT2A (0.75) | KMT2APOLBKDM4ENR1H3HTT | |
| SCHEMBL9001653 | 0.75 | KMT2A (0.75) | KMT2APOLBKDM4ENR1H3HTT | |
| SCHEMBL3837771 | 0.75 | POLB (0.58) | KMT2APOLBKDM4ENR1H3HTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210047254-A1 | METHOD FOR CONVERTING HYDROXYL GROUP OF ALCOHOL | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2021-02-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210047254-A1 | METHOD FOR CONVERTING HYDROXYL GROUP OF ALCOHOL | ADH1C, CBR1, NAP1L4 | KMT2A 2084/4885POLB 1492/4885KDM4E 1516/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.